# Achieve Clinics, Inc.

Free-to-patient immune cell banking to supercharge cancer cell therapy access and innovation 

- Canonical URL: https://wefunder.com/achieve.clinics.inc
- Entity ID: wefunder:company:135919
- Last updated: 2026-06-25T05:02:21Z
- Generated at: 2026-06-25T21:27:49Z

## Quick facts
- We proactively bank cancer patient immune cells for cell therapy (incl. pre-chemo) at no cost
- With us, industry can now pre-enroll patients for studies and manufacture with "off-the-shelf" cells
- Our unique platform generates invaluable large-format, patient records-linked research biomaterial
- Free-to-patient model fueled by PRO-Aph specimen sales: LOIs reflect ~$0.3m+/pt in potential demand
- Launch network incl. leaders from Genentech, Penn, Be The Match, xCures, +dozens in active pipeline
- Initial oncologist support and collection (apheresis) sites expected in Seattle and Houston
- Proudly endorsed by the Emily Whitehead Foundation (https://emilywhiteheadfoundation.org/)

## Active fundraises
- wefunder:fundraise:86427: 4(a)(6) successful (USD)
- wefunder:fundraise:86428: 4(a)(6) successful (USD)

## Story
Forward looking projections cannot be guaranteed.Forward looking projections cannot be guaranteed.

## FAQ
1. **Hi there, a) What is your most recent monthly burn rate? b) What is your most recent monthly cash on hand? c) Are you raising a parallel angel or VC round simultaneously? If yes, who is investing in this round?**
   - Hi Teddy, Thanks for your questions. a) Excluding one-off items like conferences, our monthly burn is minimal at approximately $100. Once cell collection and processing activities begin, we expect those to incur expenses in the single-digit thousands or more per patient. b) Our cash on hand remains materially similar to the last reported balance of $883 c) We remain engaged with angels and VCs, but the only raise terms discussed currently are what you see here. As proud and excited as we are ...

## Team
- Paul Chun (Chief Financial Officer, Co-Founder)
- Brad Heller (Chief Executive Officer, Founder)

## Q&A
- Q: Hi there, a) What is your most recent monthly burn rate? b) What is your most recent monthly cash on hand? c) Are you raising a parallel angel or VC round simultaneously? If yes, who is investing in this round?
  - A: Hi Teddy, Thanks for your questions. a) Excluding one-off items like conferences, our monthly burn is minimal at approximately $100. Once cell collection and processing activities begin, we expect those to incur expenses in the single-digit thousands or more per patient. b) Our cash on hand remains materially similar to the last reported balance of $883 c) We remain engaged with angels and VCs, but the only raise terms discussed currently are what you see here. As proud and excited as we are of our prospective partners and investors, we are not at liberty to identify any we have not already disclosed so far. Thanks again!